Tell us about your experiences with Marketplace. Enter To Win

Thai AIDS trial may help fund research

Joel Rose Sep 28, 2009
HTML EMBED:
COPY

Thai AIDS trial may help fund research

Joel Rose Sep 28, 2009
HTML EMBED:
COPY

TEXT OF STORY

Steve Chiotakis: Researchers this week are meeting in New York to see what may come of a possible new AIDS vaccine. They describe recent trial results in Thailand as a breakthrough. More now from reporter Joel Rose.


Joel Rose: While the trial results are encouraging, researchers caution that any public health benefit is still years, and billions of dollars, away.

Marshall Warren: But there’s now a proof of concept. We now know that an AIDS vaccine is possible, and it certainly makes the case for additional investment, I think, much stronger.

Marshall Warren directs the AIDS Vaccine Advocacy Coalition. He’ll join dozens of scientists, vaccine makers, government officials and philanthropic donors at a meeting this week in New York.

Warren is hoping to see more investment from pharmaceutical companies. So far, he says, they account for little of the $850 million a year flowing into AIDS vaccine research.

Warren: There’s been very limited private sector engagement. Industry has been involved in AIDS vaccine research, but not with its own money. In large part because industry finds this science very risky, and it is very risky science.

Warren says pharmaceutical companies reduced their funding after a promising AIDS vaccine from drug-maker Merck failed two years ago. He hopes the Thai results will have the opposite effect.

I’m Joel Rose for Marketplace.

Marketplace is on a mission.

We believe Main Street matters as much as Wall Street, economic news is made relevant and real through human stories, and a touch of humor helps enliven topics you might typically find…well, dull.

Through the signature style that only Marketplace can deliver, we’re on a mission to raise the economic intelligence of the country—but we don’t do it alone. We count on listeners and readers like you to keep this public service free and accessible to all. Will you become a partner in our mission today?

Your donation is critical to the future of public service journalism. Support our work today – for as little as $5 – and help us keep making people smarter.